Innovative DNA vaccine for human papillomavirus (HPV)-associated head and neck cancer.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 304, doi. 10.1038/gt.2010.151
- By:
- Publication type:
- Article
Works matching IS 09697128 AND DT 2011 AND VI 18 AND IP 3
Results: 14
1
2
Transfection of shRNA-encoding Minivector DNA of a few hundred base pairs to regulate gene expression in lymphoma cells.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 220, doi. 10.1038/gt.2010.123
- By:
- Publication type:
- Article
3
CD20-targeted measles virus shows high oncolytic specificity in clinical samples from lymphoma patients independent of prior rituximab therapy.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 313, doi. 10.1038/gt.2010.150
- By:
- Publication type:
- Article
4
Indolactam V/GLP-1-mediated differentiation of human iPS cells into glucose-responsive insulin-secreting progeny.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 283, doi. 10.1038/gt.2010.145
- By:
- Publication type:
- Article
5
Targeting tumor gene by shRNA-expressing Salmonella-mediated RNAi.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 318, doi. 10.1038/gt.2011.9
- By:
- Publication type:
- Article
6
Immune responses to adeno-associated virus type 2 encoding channelrhodopsin-2 in a genetically blind rat model for gene therapy.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 266, doi. 10.1038/gt.2010.140
- By:
- Publication type:
- Article
7
Augmentation of adenovirus 5 vector-mediated gene transduction under physiological pH conditions by a chitosan/NaHCO<sub>3</sub> solution.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 232, doi. 10.1038/gt.2010.129
- By:
- Publication type:
- Article
8
Development of murine leukemia virus-based retroviral vectors with a minimum possibility of cis-activation.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 240, doi. 10.1038/gt.2010.135
- By:
- Publication type:
- Article
9
Adenovirus-mediated human paraoxonase1 gene transfer to provide protection against the toxicity of the organophosphorus pesticide toxicant diazoxon.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 250, doi. 10.1038/gt.2010.136
- By:
- Publication type:
- Article
10
Transient expression of OCT4 is sufficient to allow human keratinocytes to change their differentiation pathway.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 294, doi. 10.1038/gt.2010.148
- By:
- Publication type:
- Article
11
Prototype development and preclinical immunogenicity analysis of a novel minimally invasive electroporation device.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 258, doi. 10.1038/gt.2010.137
- By:
- Publication type:
- Article
12
Progress and prospects: oligonucleotide-directed gene modification in mouse embryonic stem cells: a route to therapeutic application.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 213, doi. 10.1038/gt.2010.161
- By:
- Publication type:
- Article
13
Adenoviral delivery of Tousled kinase for the protection of salivary glands against ionizing radiation damage.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 275, doi. 10.1038/gt.2010.142
- By:
- Publication type:
- Article
14
Direct and long-term detection of gene doping in conventional blood samples.
- Published in:
- Gene Therapy, 2011, v. 18, n. 3, p. 225, doi. 10.1038/gt.2010.122
- By:
- Publication type:
- Article